Abstract:Compared to the conventional anti-cancer drugs, the nano-drug delivery systems (NDDS) shows a comparatively ideal therapeutic efficacy ascribing their high tumor-target capacity and efficient drug release ability. In this study, a novel macromolecular prodrug conjugate was designed and developed that is passively triggered by the acidic environment of the tumor cells and can release doxorubicin (Dox). The susceptibility of the system to the acidic environment is due to the acid volatile Schiff base covalent bond between grafted carboxymethyl chitosan (CMCs) and Dox. The chemical structure of the finalized system was characterized by 1H-NMR spectroscopy. Because of the hydrophobicity of the Dox and the hydrophilicity of the CMCs, the amphipathic polymeric drug conjugates can self-assemble into the nanoparticles in aqueous solution. The morphology and size of the nanoparticles were observed with TEM (transmission electron microscopy) and DLS (dynamic light scattering). The in vitro drug release studies demonstrated that the drug release rate of the prodrug were visibly higher in acidic conditions (pH 5.0) compared to higher pHs like 6.5 and 7.4. DLS results showed that the mean size of the prodrug nanoparticles increased as the pH of the solution decreased from 7.4 to 6.5 and 5.0. Furthermore, the cell counting kit-8 (CCK-8) assays showed that the polymeric drug nanoparticles had a cytotoxic effect on SKOV3 ovarian cancer cells while the segments of the DDS revealed comparatively lower cytotoxic effect. Moreover, confocal laser scanning microscopy (CLSM) showed that the prodrug could efficiently deliver and release Dox in the nuclei of the cancer cells while this was not observed for the Dox pure drug. These results proved that the carboxymethyl chitosan-CBA-Doxorubicin NPs have superior stabilities, low toxicities, proper sizes, and enhanced curable efficiency for in vitro controlled release. Thus, this pH-sensitive prodrug could be a potential treatment for cancer therapy in the near future.

Preparation and Characteristics of Doxorubicin-Loaded Carboxylic Acid-Functionalized Mesoporous Silica Nanoparticles

Acid-responsive intracellular doxorubicin release from click chemistry functionalized mesoporous silica nanoparticles

Doxorubicin-loaded Mn-doped SiO2 Nanospheres Coated with Carboxymethyl Chitosan: Fabrication, Characterization, and in Vitro Evaluation

Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.

In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.

Preparation and in vitro characterizations of doxorubicin-loaded micelles

Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.

Engineering Polyzwitterion And Polydopamine Decorated Doxorubicin-Loaded Mesoporous Silica Nanoparticles As A Ph-Sensitive Drug Delivery

Effect of Surface Functionalization and Pore Structure Type on the Release Performance of Mesoporous Silica Nanoparticles

Synthesis and in Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles As Ph-Sensitive Drug Delivery Systems

Mesoporous Silica Nanoparticles Combining Au Particles As Glutathione and Ph Dual-Sensitive Nanocarriers for Doxorubicin.

Thermo and pH-responsive nanocarriers based on mesocellular silica foam and poly( N -vinylcaprolactam-co-methacrylic acid): Synthesis, characterization, and in vitro cytotoxicity assay

Chitosan functionalized doxorubicin loaded poly(methacrylamide) based copolymeric nanoparticles for enhanced cellular internalization and in vitro anticancer evaluation

Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.

Multifunctional mesoporous silica nanoparticles with different morphological characteristics for in vitro cancer treatment

Ph and Thermal Dual-Responsive Nanoparticles for Controlled Drug Delivery with High Loading Content

In vitro and in silico characteristics of doxorubicin-loaded four polymeric-based polysaccharides-modified super paramagnetic iron oxide nanoparticles for cancer chemotherapy and magnetic resonance imaging

Preparation, Drug Release and Cellular Uptake of Doxorubicin-Loaded Dextran-B-poly(ɛ-caprolactone) Nanoparticles

Multifunctional Mesoporous Silica Nanoparticles Modified with Tumor-Shedable Hyaluronic Acid As Carriers for Doxorubicin

Preparation of Doxorubicin Loaded Self-Aggregated Nanoparticles Based on Cholesterol-Modified Glycol Chitosan Conjugate and Its Pharmacokinetics in Rats

Phenylboronic Acid-Modified Hollow Silica Nanoparticles for Dual-Responsive Delivery of Doxorubicin for Targeted Tumor Therapy.